It has been announced that ten leading research centres in the UK will be using DHSC funding to explore new ways to fight against AMR.
In 2018, £32 million in funding was committed by the the Department of Health and Social Care (DHSC) to the fight against antimicrobial resistance (AMR).
Following the government’s 20-year vision and 5-year national action plan published in January 2019, the uses for the funding have been announced:
- To support the development of a virtual ‘open access’ centre, led by Public Health England (PHE); the ‘open access’ centre will gather real-time patient data on resistant infections, helping clinicians to decide when to use antibiotics and cutting unnecessary prescriptions which can lead to AMR
- PHE will use £5 million to develop a fully functional model ward to identify how hospital facilities can be designed to improve control of infections
- The University of Liverpool will use £3.5 million to apply innovative genome sequencing to enable more personalised antibiotic prescribing
- The Manchester University NHS Foundation Trust will use £4.4 million to test ‘individualised’ approaches to antibiotic prescribing by bringing together patient care and clinical research
It has also been announced that Professor Dame Sally Davies, the outgoing Chief Medical Officer, will become UK special envoy on antimicrobial resistance (AMR), to aid the delivery of a ‘One Health’ response to AMR.
Professor Davies stated:
AMR is a complex challenge which needs local, national and global action. The UK should be proud of its world-leading work on AMR. We have made tangible progress but it is essential we maintain momentum. I am honoured to have been asked to continue this vital work on behalf of the UK government.
More detail is available here.